Overview
Serena Tonstad is a Public Health and Preventive Medicine provider in Loma Linda, California. Her top areas of expertise are Heterozygous Familial Hypercholesterolemia (HeFH), Homozygous Familial Hypercholesterolemia (HoFH), and Percutaneous Coronary Intervention (PCI).
Her clinical research consists of co-authoring 136 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.
Specialties
Licenses
Languages Spoken
Gender
Insurance
Accepted insurance can change. Please verify directly with the provider.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
1 Clinical Trials
Marc Miller is a Public Health and Preventive Medicine provider in Irvine, California. Dr. Miller is highly rated in 2 conditions, according to our data. His top areas of expertise are Paroxysmal Supraventricular Tachycardia (PSVT), Pacemaker Implantation, and Thrombectomy.
John Breitner is a Psychiatrist and a Public Health and Preventive Medicine provider in Palm Springs, California. Dr. Breitner is highly rated in 2 conditions, according to our data. His top areas of expertise are Alzheimer's Disease and Dementia.
Korean Community Services Inc
Nichole Quick is a Public Health and Preventive Medicine specialist and an Addiction Medicine provider in Irvine, California. Dr. Quick is highly rated in 1 condition, according to our data. Her top areas of expertise are Vitamin D Deficiency, Febrile Neutropenia, Angiomyoma, and Folliculitis. Dr. Quick is currently accepting new patients.
Frequently Asked Questions about Dr. Serena Tonstad
How do I make an appointment with Dr. Serena Tonstad?
You can book an appointment with Dr. Serena Tonstad by calling their office at 909-558-4741. MediFind provides direct contact information so you can schedule visits, second opinions, or consultations without navigating third-party calendars.
Is Dr. Serena Tonstad a top-rated expert for Heterozygous Familial Hypercholesterolemia (HeFH)?
MediFind is an objective health platform that identifies experts based on real-world data. Dr. Serena Tonstad is classified as an Experienced expert for Heterozygous Familial Hypercholesterolemia (HeFH), meaning they are among the top experts in the country for this condition. This ranking is based on their volume of patients, published research, and peer connections.
What conditions does Dr. Serena Tonstad specialize in?
While Dr. Serena Tonstad is a Public Health and Preventive Medicine, they have specific expertise in Heterozygous Familial Hypercholesterolemia (HeFH), Homozygous Familial Hypercholesterolemia (HoFH), and Percutaneous Coronary Intervention (PCI). MediFind analyzes a doctor's articles and referral patterns to identify their specific areas of focus within Public Health and Preventive Medicine.
Does Dr. Serena Tonstad participate in research or clinical trials?
Yes. Dr. Serena Tonstad has published 136 articles and abstracts on conditions like Heterozygous Familial Hypercholesterolemia (HeFH). You can view a list of Dr. Serena Tonstad's latest peer-reviewed publications and clinical trial participation on their profile to see if they are active in new treatments.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- Heterozygous Familial Hypercholesterolemia (HeFH)
- Homozygous Familial Hypercholesterolemia (HoFH)
- Percutaneous Coronary Intervention (PCI)Dr. Tonstad isExperienced. Learn about Percutaneous Coronary Intervention (PCI).